433 related articles for article (PubMed ID: 21237521)
1. FOXP3+ regulatory T cells: control of FOXP3 expression by pharmacological agents.
Ohkura N; Hamaguchi M; Sakaguchi S
Trends Pharmacol Sci; 2011 Mar; 32(3):158-66. PubMed ID: 21237521
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
[TBL] [Abstract][Full Text] [Related]
3. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1.
Ono M; Yaguchi H; Ohkura N; Kitabayashi I; Nagamura Y; Nomura T; Miyachi Y; Tsukada T; Sakaguchi S
Nature; 2007 Apr; 446(7136):685-9. PubMed ID: 17377532
[TBL] [Abstract][Full Text] [Related]
4. Foxp3 is critical for human natural CD4+CD25+ regulatory T cells to suppress alloimmune response.
Sun L; Wu J; Yi S
Transpl Immunol; 2012 Mar; 26(2-3):71-80. PubMed ID: 22079196
[TBL] [Abstract][Full Text] [Related]
5. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease.
Sakaguchi S; Ono M; Setoguchi R; Yagi H; Hori S; Fehervari Z; Shimizu J; Takahashi T; Nomura T
Immunol Rev; 2006 Aug; 212():8-27. PubMed ID: 16903903
[TBL] [Abstract][Full Text] [Related]
6. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
[TBL] [Abstract][Full Text] [Related]
7. The effect of high-mobility group box 1 protein on activity of regulatory T cells after thermal injury in rats.
Huang LF; Yao YM; Zhang LT; Dong N; Yu Y; Sheng ZY
Shock; 2009 Mar; 31(3):322-9. PubMed ID: 18665051
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of peripheral tolerance and immune regulation mediated by Treg.
Sakaguchi S; Wing K; Yamaguchi T
Eur J Immunol; 2009 Sep; 39(9):2331-6. PubMed ID: 19662638
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cells support homeostatic expansion of Foxp3+ regulatory T cells in Foxp3.LuciDTR mice.
Suffner J; Hochweller K; Kühnle MC; Li X; Kroczek RA; Garbi N; Hämmerling GJ
J Immunol; 2010 Feb; 184(4):1810-20. PubMed ID: 20083650
[TBL] [Abstract][Full Text] [Related]
11. Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis.
Sugimoto N; Oida T; Hirota K; Nakamura K; Nomura T; Uchiyama T; Sakaguchi S
Int Immunol; 2006 Aug; 18(8):1197-209. PubMed ID: 16772372
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta-producing Foxp3(+)CD8(+)CD25(+) T cells induced by iris pigment epithelial cells display regulatory phenotype and acquire regulatory functions.
Sugita S; Futagami Y; Horie S; Mochizuki M
Exp Eye Res; 2007 Nov; 85(5):626-36. PubMed ID: 17720157
[TBL] [Abstract][Full Text] [Related]
13. The role of FoxP3+CD4+CD25hi Tregs in the pathogenesis of myasthenia gravis.
Zhang Y; Wang HB; Chi LJ; Wang WZ
Immunol Lett; 2009 Jan; 122(1):52-7. PubMed ID: 19111574
[TBL] [Abstract][Full Text] [Related]
14. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
Pyzik M; Piccirillo CA
J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
[TBL] [Abstract][Full Text] [Related]
15. Expanding and converting regulatory T cells: a horizon for immunotherapy.
Khattar M; Chen W; Stepkowski SM
Arch Immunol Ther Exp (Warsz); 2009; 57(3):199-204. PubMed ID: 19479206
[TBL] [Abstract][Full Text] [Related]
16. FOXP3+ regulatory T cells: from suppression of rejection to induction of renal allograft tolerance.
Dummer CD; Carpio VN; Gonçalves LF; Manfro RC; Veronese FV
Transpl Immunol; 2012 Jan; 26(1):1-10. PubMed ID: 21939765
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide identification of human FOXP3 target genes in natural regulatory T cells.
Sadlon TJ; Wilkinson BG; Pederson S; Brown CY; Bresatz S; Gargett T; Melville EL; Peng K; D'Andrea RJ; Glonek GG; Goodall GJ; Zola H; Shannon MF; Barry SC
J Immunol; 2010 Jul; 185(2):1071-81. PubMed ID: 20554955
[TBL] [Abstract][Full Text] [Related]
18. Decrease of CD4(+)FOXP3(+) T regulatory cells in the peripheral blood of human subjects undergoing a mental stressor.
Freier E; Weber CS; Nowottne U; Horn C; Bartels K; Meyer S; Hildebrandt Y; Luetkens T; Cao Y; Pabst C; Muzzulini J; Schnee B; Brunner-Weinzierl MC; Marangolo M; Bokemeyer C; Deter HC; Atanackovic D
Psychoneuroendocrinology; 2010 Jun; 35(5):663-73. PubMed ID: 20015595
[TBL] [Abstract][Full Text] [Related]
19. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
Chen W; Jin W; Hardegen N; Lei KJ; Li L; Marinos N; McGrady G; Wahl SM
J Exp Med; 2003 Dec; 198(12):1875-86. PubMed ID: 14676299
[TBL] [Abstract][Full Text] [Related]
20. No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes.
Brusko T; Wasserfall C; McGrail K; Schatz R; Viener HL; Schatz D; Haller M; Rockell J; Gottlieb P; Clare-Salzler M; Atkinson M
Diabetes; 2007 Mar; 56(3):604-12. PubMed ID: 17327427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
